Supergene, Llc
Clinical trials sponsored by Supergene, Llc, explained in plain language.
-
New emergency drug shows promise for deadly lung clots with lower bleeding risk
Disease control Recruiting nowThis study is observing how well a new clot-dissolving drug works for patients with severe, life-threatening blood clots in the lungs (massive pulmonary embolism) during regular hospital care. It will track 20,000 patients who receive a single, weight-independent dose of the drug…
Sponsor: Supergene, LLC • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
One-Shot hope for dangerous lung clots: new drug aims to dissolve blockages safely
Disease control Recruiting nowThis study is testing a new, single-injection clot-dissolving drug for people with a serious type of lung clot who have stable blood pressure. The goal is to see if this drug can safely break up the dangerous clot in the lungs and prevent death or collapse better than a placebo. …
Phase: PHASE3 • Sponsor: Supergene, LLC • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC
-
Breakthrough drug trial aims to stop limb amputations
Disease control Recruiting nowThis study is testing whether a new clot-dissolving drug called Fortelyzin® can save a limb from amputation as effectively as emergency surgery. It will compare the drug, delivered directly into the clot, against standard surgical treatment in 170 patients with sudden, severe los…
Phase: PHASE3 • Sponsor: Supergene, LLC • Aim: Disease control
Last updated Mar 19, 2026 14:56 UTC